Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections

Journal of Clinical Pathology

Volumn 65, Issue 7, 2012, Pages 660-662

  Müller, Berit Maria ^a   Brase, Jan C ^b   Haufe, Franziska ^b   Weber, Karsten E ^b   Budzies, Jan ^a   Petry, Christoph ^b   Prinzler, Judith ^a   Kronenwett, Ralf ^b   Dietel, Manfred ^a   Denkert, Carsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Sividon Diagnostics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CANCER SECTION; CANCER RISK; CLINICAL ARTICLE; CORRELATION ANALYSIS; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; METASTASIS; MULTIGENE FAMILY; PRIORITY JOURNAL; RNA ANALYSIS; RNA EXTRACTION; SCORING SYSTEM; TISSUE INJURY; TISSUE SECTION;

BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MULTIGENE FAMILY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, NEOPLASM;

EID: 84863564975     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200716     Document Type: Article

References (12)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med 2009;360:790-800.
3. Wang Y, Klijn JGM, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671-79. (Pubitemid 40260888)
4. Filipits M, Rudas M, Jakesz R, et al. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res 2011;17:6012-20.
5. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-26. (Pubitemid 40051905)
6. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009. (Pubitemid 35461656)
7. Haas S, Park T-W, Hahne J, et al. Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue. Virchows Arch 2008;452:277-83.
8. Dietel M, Ellis IO, Hofler H, et al. Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. Virchows Arch 2007;451:19-25.
9. Bohmann K, Hennig G, Rogel U, et al. RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods. Clin Chem 2009;55:1719-27.
10. Hennig G, Gehrmann M, Stropp U, et al. Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression. Clin Chem 2010;56:1845-53.
11. Muller BM, Kronenwett R, Hennig G, et al. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue e a new option for predictive biomarker assessment in breast cancer. Diagn Mol Pathol 2011;20:1-10.
12. Zanetti-Dallenbach R, Vuaroqueaux V, Wight E, et al. Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples. Breast Cancer Res 2006;8:R51.